Stock listing

NASDAQ:ZURA Zura Bio Limited Stock

Home listing (NASDAQ) of Zura Bio Limited

Follow Zura Bio Limited into a list and get an email when it puts out news.

Share price · NASDAQ:ZURA

$0.931 USD -0.035 (-3.6%)

Close on Nov 20, 2026

Past year -74.6% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$0.919 – $1.001 USDNov 20, 2026
Volume
4.76M sharesNov 20, 2026
Market cap
$89.63M USDAt the close on Nov 20, 2026 · price × 96.33M shares outstanding
52-week range
$0.919 – $7.440 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$13.96M USDMedian day 2.65M shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Zura Bio Limited logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:ZURA · Home$0.931 USD-0.035 (-3.6%)4,756,900$0.940$1.001$0.919$0.965Close on Nov 20, 2026
Frankfurt:94E€0.845 EUR-0.060 (-6.6%)—€0.845€0.845€0.845€0.905Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:ZURA · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.931-0.035-3.6%$0.940$1.001$0.9194,756,900
$0.965-0.070-6.8%$1.010$1.045$0.9453,023,431
$1.035-0.045-4.2%$1.050$1.070$0.9833,521,789
$1.080-0.160-12.9%$1.240$1.250$1.0503,734,049
$1.2400.0000.0%$1.230$1.250$1.1304,239,089
$1.240-0.190-13.3%$1.410$1.440$1.2103,522,988
$1.430+0.025+1.8%$1.405$1.575$1.3506,940,510
$1.405+0.165+13.3%$1.170$1.530$1.16316,982,987
$1.240-2.850-69.7%$1.270$1.270$0.93464,340,588
$4.090+0.370+9.9%$3.800$4.245$3.7603,002,600
$3.720-0.300-7.5%$4.000$4.010$3.7002,655,000
$4.020+0.030+0.8%$4.120$4.200$3.8321,947,400
$3.990+0.050+1.3%$3.990$4.130$3.9001,930,200
$3.940-0.100-2.5%$4.040$4.140$3.8653,721,900
$4.040+0.190+4.9%$3.810$4.060$3.6554,074,200
$3.850-0.500-11.5%$4.350$4.490$3.8003,354,900
$4.350+0.080+1.9%$4.230$4.600$4.1104,389,400
$4.270+0.710+19.9%$3.570$4.330$3.4125,089,300
$3.560+0.200+6.0%$3.350$3.800$3.3454,294,900
$3.360-0.170-4.8%$3.540$3.595$3.2705,820,000
$3.530-0.600-14.5%$4.380$4.470$3.5008,812,100
$4.130+0.130+3.2%$4.050$4.235$3.9604,187,900
$4.000+0.190+5.0%$3.830$4.210$3.8103,317,600
$3.810-0.070-1.8%$3.910$4.060$3.7704,557,200
$3.880-0.400-9.3%$4.300$4.350$3.8604,899,700
$4.280-0.130-2.9%$4.420$4.500$4.1504,991,700
$4.410+0.180+4.3%$4.230$4.615$4.1705,748,900
$4.230+0.230+5.8%$3.950$4.780$3.85024,435,300
$4.0000.0000.0%$4.000$4.120$3.9451,606,900
$4.000-0.130-3.1%$4.130$4.350$4.0001,706,900
$4.130-0.040-1.0%$4.120$4.160$3.9052,696,100
$4.170+0.210+5.3%$3.960$4.350$3.9002,084,600
$3.960+0.030+0.8%$3.970$4.055$3.8201,427,200
$3.930-0.180-4.4%$4.110$4.190$3.9202,649,400
$4.110-0.030-0.7%$4.210$4.360$4.0752,953,800
$4.140-0.020-0.5%$4.130$4.245$4.0002,913,200
$4.160+0.160+4.0%$4.040$4.230$3.9803,325,600
$4.000-0.100-2.4%$4.100$4.190$3.9232,044,000
$4.100+0.060+1.5%$4.030$4.190$3.9201,465,000
$4.040-0.120-2.9%$4.270$4.280$3.9151,510,900
$4.160-0.170-3.9%$4.320$4.320$3.8403,433,200
$4.330-0.180-4.0%$4.525$4.550$4.1622,061,600
$4.510+0.010+0.2%$4.560$4.620$4.4502,150,200
$4.500+0.040+0.9%$4.550$4.550$4.3701,111,100
$4.460-0.110-2.4%$4.500$4.608$4.4001,657,100
$4.570-0.040-0.9%$4.720$4.840$4.5301,666,600
$4.610-0.320-6.5%$4.940$4.980$4.5841,269,700
$4.930-0.280-5.4%$5.200$5.240$4.7402,637,400
$5.2100.0000.0%$5.210$5.360$5.1501,039,100
$5.210-0.170-3.2%$5.480$5.580$5.1501,421,200
$5.380-0.330-5.8%$5.600$5.740$5.3651,150,900
$5.710-0.420-6.9%$6.040$6.050$5.6301,730,800
$6.130-0.100-1.6%$6.230$6.230$5.9001,617,100
$6.230+0.350+6.0%$5.800$6.260$5.6301,388,400
$5.880+0.210+3.7%$5.690$5.940$5.5001,773,100
$5.670+0.020+0.4%$5.670$5.870$5.485934,500
$5.650+0.110+2.0%$5.520$5.680$5.3901,096,200
$5.540-0.180-3.1%$5.680$5.680$5.3901,378,600
$5.720-0.130-2.2%$5.880$5.890$5.4901,892,700
$5.850-0.140-2.3%$6.020$6.030$5.8401,099,000
$5.990-0.330-5.2%$6.130$6.300$5.9801,794,500
$6.320+0.020+0.3%$6.370$6.490$6.1802,817,000
$6.300+0.450+7.7%$5.850$7.060$5.6198,341,800
$5.850+0.100+1.7%$5.780$5.988$5.755722,100
$5.750-0.090-1.5%$5.810$5.810$5.540796,900
Ticker
NASDAQ:ZURA
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Zura Bio Limited news

Zura Bio Limited on 6ix

Sector
Health care
Industry
Biotechnology
News releases
19 in the last 12 months · 54 in all · newest Nov 9, 2026 · oldest 2023
Decks
23 decks · latest Oct 27, 2026

Where Zura Bio Limited is listed

ListingExchangeCountryCurrency
NASDAQ:ZURA · Home listing · This pageNASDAQUnited StatesUSD
Frankfurt:94EFrankfurtGermanyEUR
Stuttgart:94EStuttgartGermanyEUR
BOATS:ZURABOATSUnited StatesUSD
Dusseldorf:94EDusseldorfGermanyEUR
Tradegate:94ETradegateGermanyEUR

Valuation

Price/book 0.5× against a median of 2.3×: 3rd lowest of 9 Biotechnology companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
−$98.02M USD
P/E
Loss
EV/sales
No revenue
EV/EBITDA
No depreciation figure on 6ix yet
Price/book
0.5×
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
0.0×
Beta vs S&P 500
1.52

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Zura Bio Limited · NASDAQ:ZURAUS$89.63M−US$98.02Mn/an/an/a0.5×n/a0.0×1.52
Brii Biosciences Limited · HKEX:2137US$91.58M−US$173.2Mn/a−63.7×n/a0.3×n/a0.0×n/a
TWi Biotechnology, Inc · TPEX:6610US$91.56MUS$88.17Mn/an/an/a6.3×n/a0.0×n/a
NeOnc Technologies Holdings, Inc. · NASDAQ:NTHIUS$90.88MUS$85.02Mn/an/an/an/an/an/a1.44
Infant Bacterial Therapeutics AB Class B · OMXSTO:IBT_BUS$88.47MUS$77.84Mn/an/an/a17.0×n/a0.0×n/a
Bio Solution Co., Ltd. · KRX:086820US$88.38MUS$79.74M137×6.2×n/a2.9×5.0%0.0×n/a
Cumberland Pharmaceuticals Inc. · NASDAQ:CPIXUS$87.57MUS$11.59M1.3×0.5×n/a1.2×273.7%0.1×0.72
Retension Pharmaceuticals, Inc. · NASDAQ:RTSNUS$87.57MUS$78.38Mn/an/an/an/an/an/an/a
Y-Biologics Inc. · KRX:338840US$87.56MUS$70.92Mn/a30.1×n/a6.8×n/a0.9×n/a
Equillium, Inc. · NASDAQ:EQUS$87.26MUS$34.71Mn/an/an/a1.7×n/a0.0×1.31
Upstream Bio, Inc. · NASDAQ:UPBUS$87.15M−US$119.4Mn/a−41.6×n/a0.4×n/a0.0×1.95
Median of the othersUS$87.98MUS$74.38M69.1×0.5×2.3×139.4%0.0×1.38

Forecasts

6 strong buy · 1 buy · Analysts' consensus from EODHD, read Nov 10, 2026. Not 6ix's view and not investment advice.

Price target
19.00 USD · Analysts' mean
EPS, year to Dec 2026
-0.79 · 5 analysts

Team and board

Officers

OfficerRole
Sandeep KulkarniCo-Founder, Chief Executive Officer and Director
Muzammil MustufaChief Business Officer

Board

DirectorRole
Amit MunshiChairman
Ajay NirulaDirector
Dan BeckerDirector
Jennifer JarrettDirector
Mark EisnerDirector
Parvinder ThiaraDirector
Sandeep KulkarniCo-Founder, Chief Executive Officer and Director
Steve SchochDirector

Events

QuarterResultsShare move
Q3 2026Oct 27, 2026 · Before open+19.9%
Q2 2026Aug 11, 2026 · Before open−1.2%
Q1 2026May 7, 2026 · Before open−7.2%
Q4 2025Mar 20, 2026−9.0%
Q3 2025Nov 13, 2025 · Before open−9.7%
Q2 2025Aug 14, 2025 · Before open+8.2%
Q1 2025May 8, 2025 · Before open+2.4%
Q4 2024Mar 25, 2025−1.1%
Q3 2024Nov 7, 2024 · Before open+4.0%
Q2 2024Aug 13, 2024 · Before open−2.4%
All 20 quarters
QuarterResultsShare move
Q1 2024May 9, 2024 · Before open−2.3%
Q4 2023Mar 28, 2024 · Before open+10.8%
Q3 2023Nov 13, 2023 · Before open−6.5%
Q2 2023Aug 14, 2023 · Before open+0.3%
Q1 2023May 31, 2023+15.1%
Q4 2022Mar 28, 2023−1.8%
Q3 2022Nov 14, 2022
Q2 2022Aug 12, 2022
Q1 2022Apr 11, 2022
Q3 2021Nov 19, 2021

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (October 2026)Investor deck51 slidesOct 27, 2026
Investor Presentation (August 2026)Investor deck50 slidesAug 11, 2026
Investor Presentation (August 2026)Investor deck51 slidesAugust 2026
Investor Presentation (July 2026)Investor deck31 slidesJul 1, 2026
Investor Presentation (May 2026)Investor deck31 slidesMay 7, 2026
Investor Presentation (March 2026)Investor deck31 slidesMar 19, 2026
Investor Presentation (March 2026)Investor deck29 slidesMar 10, 2026
Investor Presentation (February 2026)Investor deck29 slidesFeb 11, 2026
Investor Presentation (January 2026)Investor deck29 slidesJan 12, 2026
Investor Presentation (September 2025)Investor deck25 slidesSep 4, 2025
All 23 decks
DeckKindSlidesDate
Jefferies Global Healthcare Conference 2025Conference21 slidesJun 4, 2025
Investor Presentation (March 2025)Investor deck39 slidesMar 25, 2025
Investor Presentation (January 2025)Investor deck39 slidesJan 13, 2025
Investor Presentation (September 2024)Investor deck48 slidesSep 9, 2024
Investor Presentation (August 2024)Investor deck37 slidesAug 14, 2024
Investor Presentation (April 2024)Investor deck32 slidesApr 23, 2024
Investor Presentation (March 2024)Investor deck22 slidesMar 11, 2024
42nd Annual J.P. Morgan Healthcare Conference (January 2024)Conference19 slidesJan 11, 2024
Investor Presentation (October 2023)Investor deck34 slidesOct 25, 2023
Investor Presentation (July 2023)Investor deck31 slidesJul 27, 2023
Investor Presentation (June 2023)Investor deck53 slidesJun 15, 2023
Investor Presentation (April 2023)Investor deck54 slidesApr 27, 2023
SPAC Merger (June 2022)SPAC merger30 slidesJun 17, 2022

Open Decks

Financings

RaiseDate
Public offering of class A ordinary shares and pre-funded warrants
Closed: US$144M raised · US$6.25 a share · Leerink Partners +3
Dealers: Leerink Partners (co-lead), Piper Sandler (co-lead), Cantor (co-lead), Wedbush PacGrow
Feb 27, 2026

Open Financings · Read by 6ix AI from the company's releases

IPO

Went public as JATT Acquisition Corp, a blank check company (SPAC). Priced at US$10.00 a unit on Jul 13, 2021.

Price
US$10.00 a unit
Units offered
12,000,000 units
Offering size
US$120 million
Underwriters' option
Up to 1,800,000 more units
Listing
JATT U on the New York Stock Exchange
Underwriter
Raymond James
Units delivered
On or about Jul 16, 2021

Steps

StepWhen
Draft sent to the SEC in confidenceApr 8, 2021
Filed publiclyJun 15, 2021
Amended onceJul 6, 2021
Shares registered with an exchangeJul 13, 2021
Declared effective by the SECJul 13, 2021
Final prospectus, with the priceJul 14, 2021

Open IPO · From the cover of the final prospectus (424B4) filed Jul 14, 2021

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022
Research and development42.1M24.4M44.0M
Operating income-75.2M-55.2M-62.6M-2.68M
Depreciation and amortization49.0K9.00K
EBITDA-75.2M-55.2M
Income before tax-68.7M-52.4M-60.6M
Income tax00
Net income-68.7M-52.4M-60.4M-25.7M
Earnings per share, basic-1.06-0.60-2.09-91.88
Earnings per share, diluted-1.06-0.60-2.09

Balance sheet

LineFY2025FY2024FY2023FY2022
Cash and equivalents109.4M176.5M99.8M13.8K
Current assets112.3M178.7M100.8M1.78M
Property, plant and equipment126.0K91.0K
Total assets113.9M179.5M100.8M5.26M
Accounts payable1.28M733.0K2.75M2.01M
Current liabilities12.4M19.5M20.3M14.8M
Total liabilities12.4M19.5M21.3M14.8M
Shareholders' equity101.5M146.8M59.3M-32.1M
Shares outstanding73.7M65.3M43.6M279.7K

Cash flow

LineFY2025FY2024FY2023FY2022
Cash from operations-64.8M-28.1M-15.1M-1.07M
Capital spending-113.0K-75.0K
Free cash flow-64.9M-28.2M
Cash from investing-113.0K-5.08M-8.00M
Cash from financing-2.16M109.8M121.3M355.6K
Change in cash-67.1M76.7M98.2M-715.4K

Open Financials

Filings

FilingDateTypeFiled with
8-K · Current reportNov 9, 2026Current reportSEC
EFFECT · Notice that a registration is effectiveNov 4, 2026Other filingsSEC
S-3 · Registration statementOct 27, 2026Offer documentSEC
8-K · Current reportOct 27, 2026ResultsSEC
10-Q · Quarterly reportOct 27, 2026Quarterly reportSEC
S-8 · Registration statement for employee plansSep 30, 2026Offer documentSEC
144 · Notice of proposed saleAug 18, 2026Other filingsSEC
144 · Notice of proposed saleAug 17, 2026Other filingsSEC
8-K · Current reportAug 17, 2026Current reportSEC
144 · Notice of proposed saleAug 14, 2026Other filingsSEC
Show 200 filings
FilingDateTypeFiled with
144 · Notice of proposed saleAug 13, 2026Other filingsSEC
8-K · Current reportAug 11, 2026ResultsSEC
10-Q · Quarterly reportAug 11, 2026Quarterly reportSEC
8-K · Current reportJul 1, 2026Current reportSEC
3 · Initial statement of ownershipJun 22, 2026Insider tradeSEC
4 · Change in ownershipJun 22, 2026Insider tradeSEC
4 · Change in ownershipJun 22, 2026Insider tradeSEC
4 · Change in ownershipJun 22, 2026Insider tradeSEC
4 · Change in ownershipJun 22, 2026Insider tradeSEC
4 · Change in ownershipJun 22, 2026Insider tradeSEC
4 · Change in ownershipJun 22, 2026Insider tradeSEC
4 · Change in ownershipJun 22, 2026Insider tradeSEC
8-K · Current reportJun 18, 2026Management or board changeSEC
DEFA14A · Additional proxy materialMay 22, 2026Meeting noticeSEC
8-K · Current reportMay 22, 2026Management or board changeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 12, 2026Big-stake noticeSEC
8-K · Current reportMay 7, 2026ResultsSEC
10-Q · Quarterly reportMay 7, 2026Quarterly reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 6, 2026Big-stake noticeSEC
ARS · Annual report to shareholdersApr 30, 2026Annual reportSEC
DEF 14A · Proxy statementApr 30, 2026Meeting noticeSEC
8-K · Current reportApr 23, 2026Management or board changeSEC
4 · Change in ownershipApr 2, 2026Insider tradeSEC
4 · Change in ownershipApr 2, 2026Insider tradeSEC
4 · Change in ownershipApr 2, 2026Insider tradeSEC
4 · Change in ownershipApr 2, 2026Insider tradeSEC
4 · Change in ownershipApr 2, 2026Insider tradeSEC
10-K · Annual reportMar 19, 2026Annual reportSEC
8-K · Current reportMar 19, 2026ResultsSEC
8-K · Current reportMar 10, 2026Current reportSEC
4 · Change in ownershipMar 5, 2026Insider tradeSEC
3 · Initial statement of ownershipMar 5, 2026Insider tradeSEC
8-K · Current reportMar 5, 2026Current reportSEC
4 · Change in ownershipMar 2, 2026Insider tradeSEC
SCHEDULE 13D/A · Big-stake notice, amendedMar 2, 2026Big-stake noticeSEC
8-K/A · Current report, amendedFeb 26, 2026Current reportSEC
8-K · Current reportFeb 25, 2026ResultsSEC
424B5 · ProspectusFeb 25, 2026Offer documentSEC
4 · Change in ownershipFeb 24, 2026Insider tradeSEC
3 · Initial statement of ownershipFeb 24, 2026Insider tradeSEC
424B5 · ProspectusFeb 24, 2026Offer documentSEC
8-K · Current reportFeb 23, 2026Management or board changeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 17, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 13, 2026Big-stake noticeSEC
8-K · Current reportFeb 11, 2026Current reportSEC
4 · Change in ownershipJan 27, 2026Insider tradeSEC
3 · Initial statement of ownershipJan 27, 2026Insider tradeSEC
SCHEDULE 13D · Big-stake noticeJan 27, 2026Big-stake noticeSEC
8-K · Current reportJan 23, 2026Management or board changeSEC
4 · Change in ownershipJan 23, 2026Insider tradeSEC
8-K · Current reportJan 12, 2026Current reportSEC
SCHEDULE 13G · Big-stake noticeJan 2, 2026Big-stake noticeSEC
3 · Initial statement of ownershipJan 2, 2026Insider tradeSEC
8-K · Current reportJan 2, 2026Material contractSEC
8-K · Current reportDec 17, 2025Management or board changeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 14, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 14, 2025Big-stake noticeSEC
10-Q · Quarterly reportNov 13, 2025Quarterly reportSEC
8-K · Current reportNov 13, 2025ResultsSEC
8-K · Current reportOct 10, 2025Management or board changeSEC
8-K · Current reportSep 30, 2025Management or board changeSEC
8-K · Current reportSep 4, 2025Current reportSEC
8-K · Current reportAug 20, 2025Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2025Big-stake noticeSEC
10-Q · Quarterly reportAug 14, 2025Quarterly reportSEC
8-K · Current reportAug 14, 2025ResultsSEC
4 · Change in ownershipJul 17, 2025Insider tradeSEC
3 · Initial statement of ownershipJul 17, 2025Insider tradeSEC
SCHEDULE 13G · Big-stake noticeJul 16, 2025Big-stake noticeSEC
8-K · Current reportJul 1, 2025Management or board changeSEC
8-K · Current reportJun 4, 2025Current reportSEC
UPLOAD · Letter from the SECJun 3, 2025Other filingsSEC
4 · Change in ownershipMay 29, 2025Insider tradeSEC
3 · Initial statement of ownershipMay 29, 2025Insider tradeSEC
SCHEDULE 13D · Big-stake noticeMay 28, 2025Big-stake noticeSEC
3 · Initial statement of ownershipMay 28, 2025Insider tradeSEC
8-K · Current reportMay 27, 2025Current reportSEC
8-K · Current reportMay 23, 2025Meeting outcomeSEC
4 · Change in ownershipMay 22, 2025Insider tradeSEC
4 · Change in ownershipMay 22, 2025Insider tradeSEC
4 · Change in ownershipMay 22, 2025Insider tradeSEC
4 · Change in ownershipMay 22, 2025Insider tradeSEC
4 · Change in ownershipMay 22, 2025Insider tradeSEC
4 · Change in ownershipMay 22, 2025Insider tradeSEC
4 · Change in ownershipMay 22, 2025Insider tradeSEC
CORRESP · Letter to the SECMay 22, 2025Other filingsSEC
8-K · Current reportMay 20, 2025Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2025Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeMay 14, 2025Big-stake noticeSEC
4 · Change in ownershipMay 12, 2025Insider tradeSEC
UPLOAD · Letter from the SECMay 8, 2025Other filingsSEC
10-Q · Quarterly reportMay 8, 2025Quarterly reportSEC
8-K · Current reportMay 8, 2025ResultsSEC
ARS · Annual report to shareholdersApr 23, 2025Annual reportSEC
DEF 14A · Proxy statementApr 23, 2025Meeting noticeSEC
8-K · Current reportApr 17, 2025Material contractSEC
8-K · Current reportMar 25, 2025Current reportSEC
10-K · Annual reportMar 25, 2025Annual reportSEC
8-K · Current reportMar 25, 2025ResultsSEC
4 · Change in ownershipMar 3, 2025Insider tradeSEC
4 · Change in ownershipMar 3, 2025Insider tradeSEC
4 · Change in ownershipMar 3, 2025Insider tradeSEC
4 · Change in ownershipMar 3, 2025Insider tradeSEC
8-K · Current reportFeb 24, 2025Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 14, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 14, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 14, 2025Big-stake noticeSEC
5 · Annual statement of ownershipFeb 14, 2025Insider tradeSEC
5 · Annual statement of ownershipFeb 14, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 12, 2025Big-stake noticeSEC
8-K · Current reportJan 13, 2025Current reportSEC
4 · Change in ownershipDec 31, 2024Insider tradeSEC
8-K · Current reportDec 23, 2024Current reportSEC
4 · Change in ownershipDec 11, 2024Insider tradeSEC
4 · Change in ownershipDec 11, 2024Insider tradeSEC
4 · Change in ownershipDec 11, 2024Insider tradeSEC
4 · Change in ownershipDec 11, 2024Insider tradeSEC
4 · Change in ownershipDec 11, 2024Insider tradeSEC
4 · Change in ownershipDec 11, 2024Insider tradeSEC
4 · Change in ownershipDec 11, 2024Insider tradeSEC
4 · Change in ownershipDec 11, 2024Insider tradeSEC
4 · Change in ownershipDec 11, 2024Insider tradeSEC
4 · Change in ownershipNov 27, 2024Insider tradeSEC
8-K · Current reportNov 25, 2024Current reportSEC
SC 13G/A · Big-stake notice, amendedNov 14, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedNov 14, 2024Big-stake noticeSEC
SC 13G · Big-stake noticeNov 14, 2024Big-stake noticeSEC
8-K · Current reportNov 14, 2024Current reportSEC
SC 13G/A · Big-stake notice, amendedNov 14, 2024Big-stake noticeSEC
10-Q · Quarterly reportNov 7, 2024Quarterly reportSEC
8-K · Current reportNov 7, 2024ResultsSEC
8-K · Current reportOct 30, 2024Current reportSEC
8-K · Current reportOct 29, 2024Meeting outcomeSEC
8-K · Current reportOct 18, 2024Management or board changeSEC
SC 13G/A · Big-stake notice, amendedSep 23, 2024Big-stake noticeSEC
EFFECT · Notice that a registration is effectiveSep 18, 2024Other filingsSEC
CORRESP · Letter to the SECSep 16, 2024Other filingsSEC
S-3/A · Registration statement, amendedSep 16, 2024Offer documentSEC
ARS · Annual report to shareholdersSep 13, 2024Annual reportSEC
DEFA14A · Additional proxy materialSep 13, 2024Meeting noticeSEC
DEF 14A · Proxy statementSep 13, 2024Meeting noticeSEC
4 · Change in ownershipSep 13, 2024Insider tradeSEC
S-3/A · Registration statement, amendedSep 11, 2024Offer documentSEC
EFFECT · Notice that a registration is effectiveSep 11, 2024Other filingsSEC
EFFECT · Notice that a registration is effectiveSep 11, 2024Other filingsSEC
UPLOAD · Letter from the SECSep 10, 2024Other filingsSEC
8-K · Current reportSep 9, 2024Current reportSEC
4/A · Change in ownership, amendedSep 9, 2024Insider tradeSEC
4 · Change in ownershipSep 6, 2024Insider tradeSEC
4/A · Change in ownership, amendedSep 6, 2024Insider tradeSEC
4/A · Change in ownership, amendedSep 6, 2024Insider tradeSEC
4/A · Change in ownership, amendedSep 6, 2024Insider tradeSEC
POS AM · Amendment to an effective registrationSep 5, 2024Offer documentSEC
POS AM · Amendment to an effective registrationSep 5, 2024Offer documentSEC
144 · Notice of proposed saleSep 4, 2024Other filingsSEC
S-3 · Registration statementSep 3, 2024Offer documentSEC
8-K · Current reportSep 3, 2024Current reportSEC
25-NSEAug 27, 2024Other filingsSEC
8-K · Current reportAug 21, 2024Material contractSEC
8-K · Current reportAug 14, 2024Current reportSEC
424B3 · ProspectusAug 13, 2024Offer documentSEC
10-Q · Quarterly reportAug 13, 2024Quarterly reportSEC
8-K · Current reportAug 13, 2024ResultsSEC
425Aug 12, 2024Other filingsSEC
8-K · Current reportAug 12, 2024Material contractSEC
SC TO-I/AAug 9, 2024Acquisition or disposalSEC
425Aug 9, 2024Other filingsSEC
8-K · Current reportAug 9, 2024Current reportSEC
EFFECT · Notice that a registration is effectiveAug 9, 2024Other filingsSEC
424B3 · ProspectusAug 8, 2024Offer documentSEC
4 · Change in ownershipAug 8, 2024Insider tradeSEC
CORRESP · Letter to the SECAug 6, 2024Other filingsSEC
CORRESP · Letter to the SECJul 25, 2024Other filingsSEC
SC TO-I/AJul 25, 2024Acquisition or disposalSEC
S-4/A · Registration statement, amendedJul 25, 2024Offer documentSEC
425Jul 25, 2024Other filingsSEC
8-K · Current reportJul 25, 2024Management or board changeSEC
UPLOAD · Letter from the SECJul 19, 2024Other filingsSEC
425Jul 12, 2024Other filingsSEC
8-K · Current reportJul 12, 2024Current reportSEC
SC TO-IJul 12, 2024Acquisition or disposalSEC
S-4 · Registration statementJul 11, 2024Offer documentSEC
8-K/A · Current report, amendedJul 2, 2024Management or board changeSEC
4 · Change in ownershipJun 21, 2024Insider tradeSEC
4 · Change in ownershipJun 21, 2024Insider tradeSEC
4 · Change in ownershipJun 21, 2024Insider tradeSEC
4 · Change in ownershipJun 21, 2024Insider tradeSEC

This page holds 200 of 447 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Zura Bio Limited’s releases · as of Feb 27, 2026

Common shares
96,325,411
Fully diluted
96,325,411

Fully diluted

LineShares
Common shares96,325,411

Share count over time

CountShares
Nov 22, 202696,325,411

Open Cap table

Shareholders

Institutions

HolderSharesValueAs of
Montanova Capital, LLC9.44MUS$39.3MSep 30, 2026
Venrock Adviser, LLC6.43MUS$26.8MSep 30, 2026
Mpm Bioimpact LLC4.45MUS$18.5MSep 30, 2026
Great Point Partners LLC4.08MUS$17MSep 30, 2026
Siren, L.L.C.3.73MUS$15.5MSep 30, 2026
BlackRock3.7MUS$15.4MSep 30, 2026
Commodore Capital LP3.25MUS$13.5MSep 30, 2026
Braidwell LP2.65MUS$11MSep 30, 2026
Adage Capital Partners Gp, L.L.C.2.25MUS$9.36MSep 30, 2026
Saturn V Capital Management LP2.03MUS$8.46MSep 30, 2026
Show 50 holders
HolderSharesValueAs of
Vestal Point Capital, LP1.86MUS$7.74MSep 30, 2026
Foresite Capital Management VI LLC1.76MUS$7.31MSep 30, 2026
Armistice Capital, LLC1.74MUS$7.22MSep 30, 2026
QVT Financial LP1.67MUS$6.94MSep 30, 2026
Vanguard1.65MUS$6.88MSep 30, 2026
Geode Capital1.5MUS$6.26MSep 30, 2026
State Street1.29MUS$5.36MSep 30, 2026
Squadron Capital Management LLC1.2MUS$4.99MSep 30, 2026
Ikarian Capital, LLC1.02MUS$4.24MSep 30, 2026
UBS1.01MUS$4.19MSep 30, 2026
Goldman Sachs1MUS$4.16MSep 30, 2026
Citadel940KUS$3.91MSep 30, 2026
Affinity Asset Advisors, LLC800KUS$3.33MSep 30, 2026
ADAR1 Capital Management, LLC785KUS$3.27MSep 30, 2026
Millennium746KUS$3.1MSep 30, 2026
Blue Owl Capital Holdings LP735KUS$3.06MSep 30, 2026
EcoR1 Capital, LLC680KUS$2.83MSep 30, 2026
Pfizer Inc539KUS$2.18MSep 30, 2026
Fidelity530KUS$2.2MSep 30, 2026
Northern Trust499KUS$2.07MSep 30, 2026
Two Sigma461KUS$1.92MSep 30, 2026
Qube Research & Technologies Ltd453KUS$1.88MSep 30, 2026
KVP Capital Advisors, LP373KUS$1.55MSep 30, 2026
Trexquant Investment LP324KUS$1.35MSep 30, 2026
Boothbay Fund Management, LLC317KUS$1.32MSep 30, 2026
Ameriprise283KUS$1.18MSep 30, 2026
Barclays259KUS$1.08MSep 30, 2026
Wellington212KUS$880KSep 30, 2026
Schwab174KUS$726KSep 30, 2026
BNY136KUS$567KSep 30, 2026
Alberta Investment Management Corp133KUS$554KSep 30, 2026
Alps Advisors Inc126KUS$524KSep 30, 2026
Russell Investments Group, Ltd.124KUS$517KSep 30, 2026
Nuveen123KUS$512KSep 30, 2026
Dimensional106KUS$442KSep 30, 2026
Silverarc Capital Management, LLC100KUS$416KSep 30, 2026
Morgan Stanley81,077US$337KSep 30, 2026
Rhumbline Advisers74,268US$309KSep 30, 2026
Bank of America67,567US$281KSep 30, 2026
Walleye Capital LLC67,150US$279KSep 30, 2026

This page holds 50 of 119 holders. Open Shareholders

Funds

HolderSharesValueAs of
iShares Russell 2000 ETF1.46MUS$8.6MJun 30, 2026
Vanguard Extended Market Index Fund747KUS$4.41MJun 30, 2026
Fidelity Small Cap Index Fund646KUS$3.51MJul 31, 2026
iShares Russell 2000 Growth ETF554KUS$3.27MJun 30, 2026
Select Biotechnology Portfolio510KUS$2.19MMay 31, 2026
Fidelity Extended Market Index Fund225KUS$966KMay 31, 2026
iShares Micro-Cap ETF198KUS$1.17MJun 30, 2026
Schwab Small-Cap Index Fund143KUS$778KJul 31, 2026
Master Small Cap Index Series110KUS$650KJun 30, 2026
ALPS Medical Breakthroughs ETF88,879US$382KMay 31, 2026
Show 50 holders
HolderSharesValueAs of
Ultra-Small Company Fund85,348US$504KJun 30, 2026
Nuveen Small Cap Blend Index Fund78,464US$426KJul 31, 2026
Fidelity Total Market Index Fund77,980US$335KMay 31, 2026
Fidelity Series Total Market Index Fund65,934US$284KMay 31, 2026
EQ/2000 Managed Volatility Portfolio63,407US$374KJun 30, 2026
Fidelity Nasdaq Composite Index Fund58,689US$252KMay 31, 2026
Fidelity Small Cap Growth Index Fund55,233US$326KJun 30, 2026
College Retirement Equities Fund - Total Global Stock Account47,740US$282KJun 30, 2026
LVIP State Street Small-Cap Index Fund43,400US$256KJun 30, 2026
U.S. Small Cap Equity Fund32,726US$178KJul 31, 2026
Schwab Total Stock Market Index Fund31,089US$169KJul 31, 2026
Small Cap Index Fund30,476US$180KJun 30, 2026
Global X Russell 2000 ETF28,064US$152KJul 31, 2026
Avantis U.S. Small Cap Equity ETF25,846US$111KMay 31, 2026
ATM Small Cap Managed Volatility Portfolio23,664US$140KJun 30, 2026
State Street Small/Mid Cap Equity Index Portfolio21,600US$127KJun 30, 2026
MetLife Russell 2000 Index Portfolio20,836US$123KJun 30, 2026
Small-Cap Index Portfolio16,721US$98,654Jun 30, 2026
Goldman Sachs Absolute Return Tracker Fund15,148US$89,373Jun 30, 2026
1290 VT Micro Cap Portfolio13,160US$77,644Jun 30, 2026
NVIT Small Cap Index Fund13,018US$76,806Jun 30, 2026
JNL/DFA U.S. Small Cap Fund12,806US$75,555Jun 30, 2026
Small Cap Index Trust12,595US$74,311Jun 30, 2026
EQ/AB Small Cap Growth Portfolio10,580US$62,422Jun 30, 2026
EQ/Small Company Index Portfolio10,580US$62,422Jun 30, 2026
iShares Russell Small/Mid-Cap Index Fund10,221US$55,500Jul 31, 2026
DWS Small Cap Index VIP9,246US$54,551Jun 30, 2026
T. Rowe Price Small-Cap Index Fund8,889US$52,445Jun 30, 2026
EQ/Morgan Stanley Small Cap Growth Portfolio8,882US$52,404Jun 30, 2026
BlackRock Small Cap Index V.I. Fund7,929US$46,781Jun 30, 2026
Voya RussellTM Small Cap Index Portfolio7,334US$43,271Jun 30, 2026
SA Small Cap Index Portfolio6,903US$37,483Jul 31, 2026
PD Small-Cap Growth Index Portfolio5,355US$31,595Jun 30, 2026
CVT Russell 2000 Small Cap Index Portfolio5,350US$31,565Jun 30, 2026
Nationwide Small Cap Index Fund5,187US$28,165Jul 31, 2026
SmallCap Growth Fund I5,086US$27,617Jul 31, 2026
Venerable Small Cap Index Fund4,714US$27,813Jun 30, 2026
Small Company Growth Portfolio4,487US$26,473Jun 30, 2026
Voya VACS Index Series SC Portfolio4,282US$25,264Jun 30, 2026
Strategic Equity Allocation Trust2,748US$16,213Jun 30, 2026

This page holds 50 of 62 holders. Open Shareholders

Big stakes

StakeStakeSharesDateFiling
AI Biotechnology LLC18.20%19.7MFeb 26, 2026Schedule 13D
Athanor Capital15.70%11.6MJan 23, 2026Schedule 13D
Venrock Healthcare Capital Partners III, L.P.9.90%9.82MMar 31, 2026Schedule 13G
Montanova Capital, LLC9.90%9.52MMar 31, 2026Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Jennifer Jarrett
Other companies: Damora Therapeutics, Inc. (President and Chief Executive Officer in March 2026, Board Director · Since at least Mar 30, 2026); Sagimet Biosciences Inc. - Series A (Board Member · Since at least Aug 1, 2024); Syndax Pharmaceuticals, Inc. (Director · Since at least Sep 25, 2018); Arcus Biosciences, Inc. (Chief Operating Officer · Since at least Mar 14, 2018); Radius Health, Inc. (Director · May 18, 2022 – Aug 15, 2022 · Past); Surrozen, Inc. (Director · Nov 18, 2020 – Nov 18, 2020 · Past); Arena Pharmaceuticals Inc (Director · Jun 13, 2017 – Mar 11, 2022 · Past); Audentes Therapeutics Inc (Director · Jun 12, 2017 – Jan 15, 2020 · Past); Medivation Inc (Chief Financial Officer · Apr 7, 2016 – Sep 28, 2016 · Past)
Director · Since at least Mar 20, 2023
Amit Munshi
Other companies: Arcutis Biotherapeutics, Inc. (Director · Since at least Dec 4, 2025); Inhibikase Therapeutics, Inc. (Board of Directors Chair, Inhibikase; Chief Executive Officer of Orna Therapeutics · Since at least Oct 21, 2024); Damora Therapeutics, Inc. (Director · Since at least Oct 28, 2020); Social Capital Suvretta Holdings Corp IV (Director · Jun 29, 2021 – Jun 29, 2021 · Past); Pulmatrix, Inc. (Director · Jun 13, 2017 – Jan 28, 2021 · Past); Arena Pharmaceuticals Inc (President and CEO, Director · May 11, 2016 – Mar 11, 2022 · Past); EPIRUS Biopharmaceuticals Inc (Chief Executive Officer, Director · Jul 15, 2014 – Feb 27, 2016 · Past)
Chairman · Since at least Mar 20, 2023
Preston Klassen
Other companies: Regulus Therapeutics Inc (President & Head of R & D, Director · Since at least Jun 12, 2023); Metacrine Inc (Director · Sep 15, 2020 – Mar 23, 2023 · Past); Arena Pharmaceuticals Inc (EVP and CMO · Mar 20, 2017 – Mar 1, 2020 · Past); Histogen Inc (Director · Feb 7, 2014 – Jun 27, 2019 · Past); Orexigen Therapeutics Inc (EVP, Global Development · May 27, 2010 – Feb 2, 2016 · Past)
President and COO · Mar 20, 2023 – Mar 20, 2023 · Past
Dan Becker
Other companies: Acelyrin, Inc. (Director · May 4, 2023 – May 21, 2025 · Past); Day One Biopharmaceuticals Inc (Director · May 26, 2021 – Jun 22, 2023 · Past); Pandion Therapeutics Inc (Director · Jul 16, 2020 – Apr 1, 2021 · Past); Principia Biopharma Inc (Director · Sep 13, 2018 – Sep 28, 2020 · Past)
Director · Since at least May 21, 2025
Christopher Cabell
Other companies: Inhibikase Therapeutics, Inc. (President & Head of R&D · Since at least Feb 21, 2025); Pulmatrix, Inc. (Director · Jun 23, 2020 – Jan 26, 2023 · Past); Arena Pharmaceuticals Inc (EVP, Head of R&D, and CMO · Jun 2, 2020 – Nov 25, 2020 · Past)
CMO & Head of R&D · Mar 20, 2023 – May 18, 2023 · Past
Robert Lisicki
Other companies: Arcutis Biotherapeutics, Inc. (Chief Commercial Officer · Since at least Nov 5, 2026); Cadrenal Therapeutics, Inc. (Director · Jul 23, 2023 – Jan 23, 2025 · Past); Arena Pharmaceuticals Inc (EVP, Chief Commercial Officer · Aug 4, 2020 – Mar 11, 2022 · Past)
Chief Executive Officer, Director · Jan 8, 2024 – Feb 27, 2025 · Past
Eric Hyllengren
Other companies: Tenaya Therapeutics, Inc. (Chief Financial Officer · Since at least Jun 29, 2026); Atara Biotherapeutics, Inc. (EVP, CFO and COO · Apr 1, 2023 – Mar 3, 2025 · Past)
Chief Financial Officer · Since at least Jul 1, 2025
Mark Eisner
Other companies: Jade Biosciences, Inc. (Director · Since at least Jun 25, 2026); Vir Biotechnology, Inc. (EVP and Chief Medical Officer · Since at least Jun 3, 2024)
Director · Since at least Feb 21, 2026
Sandeep Kulkarni
Other companies: Amanat Acquisition Corp (Director and Chairman, Director · Since at least May 18, 2026); Tourmaline Bio Inc. (CEO, Director · Since at least Oct 19, 2023)
Co-Founder, Chief Executive Officer and Director · Since at least Mar 20, 2023
Someit Sidhu
Other companies: JATT III Acquisition Corp (CEO and Chairman, Director · Since at least Aug 25, 2026); JATT II Acquisition Corp (Chief Executive Officer, Director · Since at least Apr 16, 2026)
Director · Jul 13, 2021 – May 21, 2025 · Past
All 26 people
PersonSeat
Steve Schoch
Other companies: 23Andme Holding Co (Chief Financial Officer · Jun 16, 2021 – Aug 20, 2022 · Past); Arena Pharmaceuticals Inc (Director · Jun 11, 2021 – Mar 11, 2022 · Past)
Director · Since at least Mar 20, 2023
Verender S Badial
Other companies: JATT III Acquisition Corp (Director · Since at least Aug 25, 2026); JATT II Acquisition Corp (Director · Since at least Apr 16, 2026)
Chief Financial Officer · Jul 13, 2021 – May 8, 2025 · Past
Neil Murray Hamilton Graham
Other companies: Allakos Inc (Director · Aug 25, 2023 – May 15, 2025 · Past)
Director · Mar 20, 2023 – May 21, 2025 · Past
Parvinder Thiara
Other companies: Tourmaline Bio Inc. (Director · Since at least Oct 19, 2023)
Director · Since at least Jun 22, 2023
Ajay NirulaDirector · Since at least Feb 21, 2026
Gary WhaleChief Technology Officer · Since at least Mar 20, 2023
Javier Cote-SierraDirector · Jul 13, 2021 – Jul 13, 2021 · Past
Josh DistlerDirector · Jul 13, 2021 – Jul 13, 2021 · Past
Kim DavisChief Legal Officer · Since at least Mar 20, 2023
Kiran NistalaSee Remarks · Since at least Nov 30, 2023
Marlyn Teresa MathewVP, Principal Acctg. Officer · Since at least Apr 17, 2026
Michael HowellSee Remarks · Mar 20, 2023 – Jun 18, 2024 · Past
Mir Tauhid AliChief Operating Officer, Director · Jul 13, 2021 – Jul 13, 2021 · Past
Muzammil MustufaChief Business Officer · Since at least May 13, 2026
Theresa LowryEVP and CHRO · Mar 20, 2023 – Mar 20, 2023 · Past
van Amstel Arnout PloosDirector · Jul 13, 2021 – May 21, 2025 · Past

Open People

Log in to ask 6ix AI your own questions about Zura Bio Limited.